CVNA vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CVNA presents a stark dichotomy between explosive growth and fragile fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the company has achieved massive earnings growth (946.7% YoY) and strong liquidity (Current Ratio 4.31), it trades at a severe premium to its Graham Number ($67.9) and Intrinsic Value ($249.87). The current price of $409.08 reflects high growth expectations that are not yet supported by deterministic health metrics or insider conviction. Consequently, the stock is a high-momentum play with significant underlying fundamental risk.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
CVNA vs TSLA: Head-to-Head Comparison
This page compares Carvana Co. (CVNA) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.